Edwards Lifesciences (EW) PT Lowered to $200 at Raymond James

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. IBM
2. PRIM
3. META
4. KFY
5. ABBV
6. MU
7. DPZ
8. NAVN
9. DFTX
10. NVEC

Go back to Edwards Lifesciences (EW) PT Lowered to $200 at Raymond James

Edwards Lifesciences (EW) PT Raised to $200 at Stifel

April 24, 2019 8:36 AM EDT

Stifel analyst Rick Wise raised the price target on Edwards Lifesciences (NYSE: EW) to $200.00 (from $190.00) while maintaining a Buy rating.

Overall Solid Start to 2019 Despite Underwhelming 1Q19 TAVR Growth... More

Edwards Lifesciences (EW) PT Raised to $184 at Deutsche Bank

April 24, 2019 7:14 AM EDT

Deutsche Bank raised its price target on Edwards Lifesciences (NYSE: EW) to $184.00 (from $164.00) while maintaining a Hold rating.

... More

Edwards Lifesciences (EW) PT Raised to $186 at RBC Capital

April 24, 2019 6:39 AM EDT

RBC Capital analyst Brandon Henry raised the price target on Edwards Lifesciences (NYSE: EW) to $186.00 (from $182.00) while maintaining a Outperform rating following results.

... More

Edwards Lifesciences (EW) Tops Q1 EPS by 10c; Raises Outlook

April 23, 2019 4:16 PM EDT

Edwards Lifesciences (NYSE: EW) reported Q1 EPS of $1.32, $0.10 better than the analyst estimate of $1.22. Revenue for the quarter came in at $993 million versus the consensus estimate of $989.61 million.

GUIDANCE:

Edwards Lifesciences sees FY2019 EPS of $5.10-$5.35, from $5.05 to $5.30 and versus... More